Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy

被引:8
|
作者
Okamoto, Akinao [1 ]
Abe, Akihiro [1 ]
Okamoto, Masataka [1 ]
Kobayashi, Tsukane [2 ]
Terazawa, Tomohiko [3 ]
Inaguma, Yoko [1 ]
Tokuda, Masutaka [1 ]
Yanada, Masamitsu [1 ]
Morishima, Satoko [1 ]
Kanie, Tadaharu [1 ]
Yamamoto, Yukiya [1 ]
Tsuzuki, Motohiro [1 ]
Akatsuka, Yoshiki [1 ]
Mizuta, Shuichi [1 ]
Yoshikawa, Tetsushi [4 ]
Emi, Nobuhiko [1 ]
机构
[1] Fujita Hlth Univ, Dept Hematol & Med Oncol, Sch Med, Toyoake, Aichi 4701192, Japan
[2] Fujita Hlth Univ, Dept Dermatol, Sch Med, Toyoake, Aichi 4701192, Japan
[3] Fujita Hlth Univ, Dept Pharm, Sch Med, Toyoake, Aichi 4701192, Japan
[4] Fujita Hlth Univ, Dept Pediat, Sch Med, Toyoake, Aichi 4701192, Japan
关键词
Varicella zoster virus; Rituximab; Hepatitis; Disseminated intravascular coagulopathy; RANDOMIZED CONTROLLED-TRIAL; INTERSTITIAL PNEUMONIA; IMMUNE-RESPONSES; ELDERLY-PATIENTS; PLUS RITUXIMAB; HERPES-ZOSTER; TRANSPLANTATION; RISK; THERAPY; VACCINE;
D O I
10.1007/s12185-012-1160-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Severe disseminated varicella zoster virus (VZV) infection rarely occurs in patients who are not recipients of hematopoietic stem cell transplantation. This report concerns severe disseminated VZV infection in a diffuse large B cell lymphoma (DLBCL) patient treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone (R-CHOP). The patient was an 82-year-old male with DLBCL who had a history of type II diabetes mellitus. He incurred VZV infection with severe hepatitis and disseminated intravascular coagulopathy after three courses of R-CHOP. When the VZV infection occurred, anti-VZV IgG was not detected and lymphopenia was observed. We initiated treatment with acyclovir, immunoglobulin, and thrombomodulin alpha, and rescued this patient. We suggest that the use of chemotherapy for immune-suppressed elderly lymphoma patients may involve the risk of severe VZV infection.
引用
收藏
页码:516 / 520
页数:5
相关论文
共 50 条
  • [1] Severe hepatitis associated with varicella zoster virus infection in a patient with diffuse large B cell lymphoma treated with rituximab-CHOP chemotherapy
    Akinao Okamoto
    Akihiro Abe
    Masataka Okamoto
    Tsukane Kobayashi
    Tomohiko Terazawa
    Yoko Inaguma
    Masutaka Tokuda
    Masamitsu Yanada
    Satoko Morishima
    Tadaharu Kanie
    Yukiya Yamamoto
    Motohiro Tsuzuki
    Yoshiki Akatsuka
    Shuichi Mizuta
    Tetsushi Yoshikawa
    Nobuhiko Emi
    International Journal of Hematology, 2012, 96 : 516 - 520
  • [2] Rituximab-CHOP versus CHOP alone in patients with diffuse large B cell lymphoma.
    Cetiner, Mustafa
    Salepci, Taflan
    Atesoglu, Elif Birtas
    Gumus, Mahmut
    Guven, Aslihan
    Undar, Levent
    Tuglular, Tulin Firatli
    Bayik, Mahmut
    BLOOD, 2006, 108 (11) : 259B - 260B
  • [3] PROGNOSTIC FACTORS AND OUTCOMES IN PRIMARY DIFFUSE LARGE B-CELL LYMPHOMA OF ADRENAL GLAND TREATED WITH RITUXIMAB-CHOP CHEMOTHERAPY
    Hyun, S. Y.
    Kim, Y. R.
    Eun, J. Ji
    Kim, J. S.
    Yoon, D. H.
    Suh, C. W.
    Shin, H. J.
    Mun, Y. C.
    Park, Y.
    Do, Y. R.
    Jeong, S. H.
    Park, J. S.
    Park, E. K.
    Jang, J. S.
    Lee, W. S.
    Lee, H. W.
    Eom, H. S.
    Ahn, J. S.
    Jeong, J. H.
    Baek, S. K.
    Kim, S. J.
    Kim, W. S.
    HAEMATOLOGICA, 2012, 97 : 659 - 659
  • [4] Neutropenic and Non-Neutropenic Fever In Diffuse Large B-Cell Lymphoma Patients Treated With Rituximab-CHOP Chemotherapy
    Park, Silvia
    Kim, Won Seog
    Kim, Seok Jin
    Hong, Jung Yong
    BLOOD, 2013, 122 (21)
  • [5] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, Thomas M.
    Weller, Edie A.
    Morrison, Vicki A.
    Gascoyne, Randy D.
    Cassileth, Peter A.
    Cohn, Jeffrey B.
    Dakhil, Shaker R.
    Woda, Bruce
    Fisher, Richard I.
    Peterson, Bruce A.
    Horning, Sandra J.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) : 3121 - 3127
  • [6] Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma
    Habermann, T
    Weller, E
    Morrison, V
    Gascoyne, R
    Cassileth, P
    Cohn, J
    Dakhil, S
    Woda, B
    Fisher, R
    Peterson, B
    Horning, S
    ANNALS OF ONCOLOGY, 2005, 16 : 103 - 103
  • [7] Toxicity and Response Among Octogenarians and Nonagenarians with Diffuse Large B Cell Lymphoma Treated with Rituximab-CHOP Therapy
    Huntington, Scott F.
    Sharifi, Mahsa
    Greer, John P.
    Morgan, David
    Reddy, Nishitha
    BLOOD, 2010, 116 (21) : 741 - 741
  • [8] A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy
    Kim, Kyung Min
    Yoon, Dok Hyun
    Lee, Seung Geun
    Lim, Sung Nam
    Sug, Lyu Jin
    Huh, Jooryung
    Suh, Cheolwon
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2009, 24 (03) : 525 - 528
  • [9] Effect of Nutritional Status on Survival Outcome of Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP
    Park, Silvia
    Han, Boram
    Cho, Jae Won
    Woo, Sook-young
    Kim, Seonwoo
    Kim, Seok Jin
    Kim, Won Seog
    NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2014, 66 (02): : 225 - 233
  • [10] Early relapse in a case of primary bone marrow diffuse large B-cell lymphoma treated with rituximab-CHOP
    Wang, Wanning
    Zhou, Guang-yu
    Zhang, Wenlong
    IMMUNOTHERAPY, 2017, 9 (05) : 379 - 385